[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100551198":3},{"organization":4,"armGroups":7,"interventions":8,"overallOfficials":13,"centralContacts":24,"locations":7,"responsibleParty":29,"collaborators":7,"id":32,"slug":33,"hasResults":34,"nctId":35,"briefTitle":36,"officialTitle":36,"acronym":7,"eligibilityCriteria":37,"healthyVolunteers":34,"sex":38,"minAge":39,"maxAge":7,"enrollmentInfo":40,"targetDuration":7,"studyType":43,"phases":7,"briefSummary":44,"conditions":45,"keywords":7,"overallStatus":47,"whyStopped":7,"lastUpdateSubmitDate":48,"lastUpdatePostDateStruct":49,"startDateStruct":52,"completionDateStruct":54,"leadSponsor":56,"locationsCount":7},{"fullName":5,"class":6},"Assiut University","OTHER",null,[9],{"type":10,"name":11,"description":12,"armGroupLabels":7,"otherNames":7},"DEVICE","fibroscan","Fibroscan examination with controlled attenuation parameter\"CAP\" (Echosens FibroScan ® Compact 530) for evaluation of steatosis and its degree (by CAP score) and fibrosis stage by liver stiffness measurement(LSM)",[14,17,20,22],{"name":15,"affiliation":5,"role":16},"Taiseer Mohamed Kamal El Deen, resident","PRINCIPAL_INVESTIGATOR",{"name":18,"affiliation":5,"role":19},"Waleed Attia Hassan, A.professor","STUDY_DIRECTOR",{"name":21,"affiliation":5,"role":19},"Sahar Mohammed Hassany, professor",{"name":23,"affiliation":5,"role":19},"Mohamed Osman Abdelhameed, Lecturer",[25],{"name":15,"role":26,"phone":27,"phoneExt":7,"email":28},"CONTACT","01080718330","totym036@gmail.com",{"type":16,"investigatorFullName":30,"investigatorTitle":31,"investigatorAffiliation":5,"oldNameTitle":7,"oldOrganization":7},"Taiseer Mohamed Kamal El Deen Hasanin Mohamed","Assistant Lecturer","100551198","frequency-of-metabolic-dysfunction-associated-fatty-liver-disease-in-patients-with-acute-coronary-syndromes-100551198",false,"NCT06456970","Frequency of Metabolic Dysfunction Associated Fatty Liver Disease in Patients With Acute Coronary Syndromes","Inclusion Criteria:\n\nAny Patient above the age of 18 years old presented with acute coronary syndromes {myocardial infarction (MI), non-ST elevation myocardial infarction (NSTEMI), unstable angina} underwent coronary angiography within admission.\n\nExclusion Criteria:\n\n1. Patients refused to participate.\n2. Patients with history of alcohol or drug abuse.\n3. Patients have hepatitis C or hepatitis B infection.\n4. Patients have primary or secondary hepatic malignancies\n5. Pregnant women.","ALL","18 Years",{"count":41,"type":42},140,"ESTIMATED","OBSERVATIONAL","Aim of the research is to assess frequency of MAFLD among patients with acute coronary syndromes (ACS).",[46],"Fatty Liver","NOT_YET_RECRUITING","2024-06-12",{"date":50,"type":51},"2024-06-13","ACTUAL",{"date":53,"type":42},"2024-07-01",{"date":55,"type":42},"2026-07-01",{"name":5,"class":6}]